These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18649639)

  • 41. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.
    Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.
    Grosse-Sundrup M; Henneman JP; Sandberg WS; Bateman BT; Uribe JV; Nguyen NT; Ehrenfeld JM; Martinez EA; Kurth T; Eikermann M
    BMJ; 2012 Oct; 345():e6329. PubMed ID: 23077290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle relaxant use for tracheal intubation in pediatric anaesthesia: a survey of clinical practice in Germany.
    Nauheimer D; Fink H; Fuchs-Buder T; Geldner G; Hofmockel R; Ulm K; Wallek B; Blobner M
    Paediatr Anaesth; 2009 Mar; 19(3):225-31. PubMed ID: 19175884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuromuscular blockade.
    Neigh JL
    Surg Clin North Am; 1975 Aug; 55(4):837-50. PubMed ID: 241125
    [No Abstract]   [Full Text] [Related]  

  • 48. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
    Martin-Flores M; Paré MD; Campoy L; Gleed RD
    Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting).
    Fuchs-Buder T; Mencke T
    Eur J Anaesthesiol Suppl; 2001; 23():53-9. PubMed ID: 11766248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cucurbit[n]uril type hosts for the reversal of steroidal neuromuscular blocking agents.
    Macartney DH
    Future Med Chem; 2013 Nov; 5(17):2075-89. PubMed ID: 24215347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuromuscular block and current treatment strategies for its reversal in children.
    Meretoja OA
    Paediatr Anaesth; 2010 Jul; 20(7):591-604. PubMed ID: 20642658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversal of neuromuscular blockade with sugammadex or neostigmine/atropine: Effect on postoperative gastrointestinal motility.
    Sen A; Erdivanli B; Tomak Y; Pergel A
    J Clin Anesth; 2016 Aug; 32():208-13. PubMed ID: 27290978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neostigmine vs. sugammadex: observational cohort study comparing the quality of recovery using the Postoperative Quality Recovery Scale.
    Amorim P; Lagarto F; Gomes B; Esteves S; Bismarck J; Rodrigues N; Nogueira M
    Acta Anaesthesiol Scand; 2014 Oct; 58(9):1101-10. PubMed ID: 25179550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 60. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.